News & Events

Dec 02, 2021

Press Releases

ViaCyte’s Stem Cell-Derived Treatment for Type 1 Diabetes Shows Promising Results in Two Published Studies

Findings from an international, first-in-human clinical trial show that the ViaCyte stem cell-derived therapy can produce insulin in people with type 1 diabetes Results from the proof-of-concept study reported in Cell Reports Medicine and Cell Stem Cell SAN DIEGO, December 2, 2021 — ViaCyte, Inc., a clinical-stage regenerative medicine company focused on developing novel cell […]

Read More

Sign up for updates

To have our press releases and major updates sent to you, please provide your name and email address.